Mylan
E869054
Mylan is a global generic and specialty pharmaceuticals company known for producing a wide range of affordable medicines and healthcare products.
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
generic drug manufacturer
ⓘ
pharmaceutical company ⓘ |
| businessModel | development, manufacturing and marketing of generic drugs ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| focusesOn |
access to healthcare
ⓘ
affordable medicines ⓘ |
| formerHeadquartersLocation | Morgantown, West Virginia NERFINISHED ⓘ |
| foundedBy |
Don Panoz
NERFINISHED
ⓘ
Milan Puskar NERFINISHED ⓘ |
| hasKeyTherapeuticAreas |
allergy and anaphylaxis
ⓘ
cardiovascular diseases ⓘ central nervous system disorders ⓘ infectious diseases ⓘ respiratory diseases ⓘ |
| hasManufacturingFacilitiesIn |
Europe
NERFINISHED
ⓘ
India NERFINISHED ⓘ United States NERFINISHED ⓘ |
| headquartersLocation | Canonsburg, Pennsylvania NERFINISHED ⓘ |
| inception | 1961 ⓘ |
| industry |
generic pharmaceuticals
ⓘ
pharmaceuticals ⓘ specialty pharmaceuticals ⓘ |
| knownFor |
focus on affordability of medicines
ⓘ
large portfolio of generic drugs ⓘ |
| marketSegment |
government tenders
ⓘ
hospital ⓘ retail pharmacy ⓘ |
| mergedInto | Viatris NERFINISHED ⓘ |
| mergerCompletionDate | 2020 ⓘ |
| mergerPartner | Upjohn NERFINISHED ⓘ |
| notableProduct | EpiPen NERFINISHED ⓘ |
| notableProductType | epinephrine auto-injector ⓘ |
| offers |
biosimilars
ⓘ
branded generics ⓘ injectable medicines ⓘ oral solid dosage forms ⓘ |
| operatesIn | global ⓘ |
| parentCompanyAfterMerger | Viatris NERFINISHED ⓘ |
| productType |
active pharmaceutical ingredients
ⓘ
generic medicines ⓘ over-the-counter products ⓘ specialty medicines ⓘ |
| regulatoryRegion |
European Medicines Agency
NERFINISHED
ⓘ
United States Food and Drug Administration NERFINISHED ⓘ |
| stockExchangeListing | NASDAQ NERFINISHED ⓘ |
| tickerSymbol | MYL NERFINISHED ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.